Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: A new hypothesis to explain persistence of botulinum a poisoning

Canadian Journal of Physiology and Pharmacology

Volumn 77, Issue 9, 1999, Pages 679-688

  Raciborska, Dorota A ^a   Charlton, Milton P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Botulism; Dystonia; Neurotoxin; SNAP receptor; Torticollis

Indexed keywords

BOTULINUM TOXIN A; PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN;

ANIMAL CELL; BOTULISM; CONFERENCE PAPER; CONTROLLED STUDY; DYSTONIA; IMMUNOREACTIVITY; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; TORTICOLLIS;

EID: 0032692933     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-089     Document Type: Conference Paper

References (85)

1. Bennett, M.K., Calakos, N., Kreiner, T., and Scheller, R.H. 1992a. Synaptic vesicle membrane proteins interact to form a multimeric complex. J. Cell Biol. 116: 761-775.
2. Bennett, M.K., Calakos, N., and Scheller, R.H. 1992b. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science (Washington, D.C.), 257: 255-259.
3. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Südhof, T.C., Jahn, R., and Niemann, H. 1994. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269:1617-1620.
4. Blasi, J., Chapman, E.R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Südhof, T.C., Niemann, H., and Jahn, R. 1993a. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature (London), 365: 160-163.
5. Blasi, J., Chapman, E.R., Yamasaki, S., Binz, T., Niemann, H., and Jahn, R. 1993b. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12: 4821-4828.
6. Brin, M.F., Blitzer, A., Fahn, S., Gould, W., and Lovelace, R.E. 1989. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Movement Disorders, 4: 287-296.
7. Cànaves, J.M., and Montal, M. 1998. Assembly of a ternary complex by the predicted minimal coiled-coil-forming domains of syntaxin, SNAP-25, and synaptobrevin. A circular dichroism study. J. Biol. Chem. 273: 34 214 - 34 221.
8. Chapman, E.R., An, S., Barton, N., and Jahn, R. 1994. SNAP-25, a t-SNARE which binds to both syntaxin and synaptobrevin via domains that may form coiled coils. J. Biol. Chem. 269: 27 427 - 27 432.
9. Cull-Candy, S.G., Lundh, H., and Thesleff, S. 1976. Effects of botulinum toxin on neuromuscular transmission in the rat. J. Physiol. (London), 260: 177-203.
10. de Paiva, A., Meunier, F.A., Molgo, J., Aoki, K.R., and Dolly, J.O. 1999. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc. Natl. Acad. Sci. U.S.A. 96: 3200-3205.
11. Dolly, J.O., Lande, S., and Wray, D.W. 1987. The effects of in vitro application of purified botulinum neurotoxin at mouse motor nerve terminals. J. Physiol.(London), 386: 475-484.
12. Dreyer, F., Rosenberg, F., Becker, C., Bigalke, H., and Penner, R. 1987. Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin. Naunyn Schmiedebergs Arch. Pharmacol. 335: 1-7.
13. Duchen, L.W. 1972. Motor nerve growth induced by botulinum toxin as a regenerative phenomenon. Proc. R. Soc. Med. 65: 196-197.
14. Ekong, T.A., McLellan, K., and Sesardic, D. 1995. Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations. J. Immunol. Methods, 180: 181-191.
15. Eleopra, R., Tugnoli, V., Rossetto, O., De Grandis, D., and Montecucco, C. 1998. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci. Lett. 256: 135-138.
16. Eleopra, R., Tugnoli, V., Rossetto, O., Montecucco, C., and Degrandis, D. 1997. Botulinum neurotoxin serotype-C: a novel effective botulinum toxin therapy in human. Neurosci. Lett. 224: 91-94.
17. el Far, O., Charvin, N., Lévêque, C., Martin-Moutot, N., Takahashi, M., and Seagar, M.J. 1995. Interaction of a synaptobrevin (VAMP)-syntaxin complex with presynaptic calcium channels. FEBS Lett. 361: 101-105.
18. Encinar, J.A., Fernández, A., Ferragut, J.A., González-Ros, J.M., DasGupta, B.R., Montal, M., and Ferrer-Montiel, A. 1998. Structural stabilization of botulinum neurotoxins by tyrosine phosphorylation. FEBS Lett. 429: 78-82.
19. Erdal, E., Bartels, F., Binscheck, T., Erdmann, G., Frevert, J., Kistner, A., Weller, U., Wever, J., and Bigalke, H. 1995. Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn Schmiedebergs Arch. Pharmacol. 351: 67-78.
20. Ferrer-Montiel, A.V., Cánaves, J.M., DasGupta, B.R., Wilson, M.C., and Montal, M. 1996. Tyrosine phosphorylation modulates the activity of clostridial neurotoxins. J. Biol. Chem. 271: 18 322 - 18 325.
21. Ferrer-Montiel, A.V., Gutiérrez, L.M., Apland, J.P., Cánaves, J.M., Gil, A., Viniegra, S., Biser, J.A., Adler, M., and Montal, M. 1998. The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett. 435: 84-88.
22. Foran, P., Lawrence, G.W., Shone, C.C., Foster, K.A., and Dolly, J.O. 1996. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry, 35: 2630-2636.
23. Galli, T., Garcia, E.P., Mundigl, O., Chilcote, T.J., and De Camilli, P. 1995. V- and t-SNAREs in neuronal exocytosis: a need for additional components to define sites of release. Neuropharmacology, 34: 1351-1360.
24. Gansel, M., Penner, R., and Dreyer, F. 1987. Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals. Pfluegers Arch. Eur. J. Physiol. 409: 533-539.
25. Giladi, N. 1997. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J. Neurol. Sci. 152: 132-135.
26. Gomez, S., and Queiroz, L.S. 1982. The effects of black widow spider venom on the innervation of muscles paralysed by botulinum toxin. Q. J. Exp. Physiol. 67: 495-506.
27. Gonzalo, S., and Linder, M.E. 1998. SNAP-25 palmitoylation and plasma membrane targeting require a functional secretory pathway. Mol. Biol. Cell, 9: 585-597.
28. Greene, P.E., and Fahn, S. 1993. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Movement Disorders, 8: 479-483.
29. Gundersen, C.B., Katz, B., and Miledi, R. 1981. The reduction of endplate responses by botulinum toxin. Proc. R. Soc. London Ser. B, Biol. Sci. 213: 489-493.
30. Hanig, J.P., and Lamanna, C. 1979. Toxicity of botulinum toxin: a stoichiometric model for the locus of its extraordinary potency and persistence at the neuromuscular junction. J. Theor. Biol. 77: 107-113.
31. Hayashi, T., McMahon, H., Yamasaki, S., Binz, T., Hata, Y., Südhof, T.C., and Niemann, H. 1994. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J. 13: 5051-5061.
32. Hayashi, T., Yamasaki, S., Nauenburg, S., Binz, T., and Niemann, H. 1995. Disassembly of the reconstituted synaptic vesicle membrane fusion complex in vitro. EMBO J. 14: 2317-2325.
33. Hess, D.T., Slater, T.M., Wilson, M.C., and Skene, J.H. 1992. The 25 kDa synaptosomal-associated protein SNAP-25 is the major methionine-rich polypeptide in rapid axonal transport and a major substrate for palmitoylation in adult CNS. J. Neurosci. 12: 4634-4641.
34. Hodel, A. 1998. SNAP-25. Int. J. Biochem. Cell. Biol. 30: 1069-1073.
35. Hohne-Zell, B., and Gratzl, M. 1996. Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers. FEBS Lett. 394: 109-116.
36. Holland, R.L., and Brown, M.C. 1981. Nerve growth in botulinum toxin poisoned muscles. Neuroscience, 6: 1167-1179.
37. Honer, W.G., Hu, L., and Davies, P. 1993. Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex. Brain Res. 609: 9-20.
38. Igarashi, M., Tagaya, M., and Komiya, Y. 1997. The soluble N-ethylmaleimide-sensitive factor attached protein receptor complex in growth cones: molecular aspects of the axon terminal development. J. Neurosci. 17: 1460-1470.
39. Ignarro, L.J. 1990. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67: 1-7.
40. Jankovic, J. 1994. Botulinum toxin in movement disorders. Curr. Opin. Neurol. 7: 358-366.
41. Kee, Y., Lin, R.C., Hsu, S.C., and Scheller, R.H. 1995. Distinct domains of syntaxin are required for synaptic vesicle fusion complex formation and dissociation. Neuron, 14: 991-998.
42. Lane, S.R., and Liu, Y. 1997. Characterization of the palmitoylation domain of SNAP-25. J. Neurochem. 69: 1864-1869.
43. Leist, M., Fava, E., Montecucco, C., and Nicotera, P. 1997. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 9: 1488-1498.
44. Li, J.-Y., Jahn, R., and Dahlström, A. 1996. Axonal transport and targeting of the t-SNAREs SNAP-25 and syntaxin 1 in the peripheral nervous system. Eur. J. Cell Biol. 70: 12-22.
45. Lindgren, C.A., and Laird, M.V. 1994. Nitroprusside inhibits neurotransmitter release at the frog neuromuscular junction. Neuroreport 5: 2205-2208.
46. Lupa, M.T., and Yu, S.P. 1986. A comparison of miniature endplate potentials at normal, denervated, and long-term botulinum toxin type A poisoned frog neuromuscular junctions. Pfluegers Arch. Eur. J. Physiol. 407: 476-481.
47. 2+-independent synaptic vesicle release. Neuron, 12: 1235-1244.
48. Meffert, M.K., Calakos, N.C., Scheller, R.H., and Schulman, H. 1996. Nitric oxide modulates synaptic vesicle docking/fusion reactions. Neuron, 16: 1229-1236.
49. Mezaki, T., Kaji, R., Kohara, N., Fujii, H., Katayama, M., Shimizu, T., Kimura, J., and Brin, M.F. 1995. Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study. Neurology, 45: 506-508.
50. 2+ channel activity. Neuroscience, 65: 905-915.
51. Molgo, J., Siegel, L.S., Tabti, N., and Thesleff, S. 1989. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D. J. Physiol. (London), 411: 195-205.
52. Montecucco, C., and Schiavo, G. 1993. Tetanus and botulism neurotoxins: a new group of zinc proteases. Trends Biochem. Sci. 18: 324-327.
53. Moore, P. 1995. Handbook of botulinum toxin treatment. Blackwell Science Ltd., Cambridge, pp. 1-289.
54. Osen-Sand, A., Catsicas, M., Staple, J.K., Jones, K.A., Ayala, G., Knowles, J., Grenningloh, G., and Catsicas, S. 1993. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature (London), 364: 445-448.
55. Osen-Sand, A., Staple, J.K., Naldi, E., Schiavo, G., Rossetto, O., Petitpierre, S., Malgaroli, A., Montecucco, C., and Catsicas, S. 1996. Common and distinct fusion proteins in axonal growth and transmitter release. J. Comp. Neurol. 367: 222-234.
56. Otto, H., Hanson, P.I., Chapman, E.R., Blasi, J., and Jahn, R. 1995. Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex. Biochem. Biophys. Res. Commun. 212: 945-952.
57. Oyler, G.A., Higgins, G.A., Hart, R.A., Battenberg, E., Billingsley, M., Bloom, F.E., and Wilson, M.C. 1989. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J. Cell Biol. 109: 3039-3052.
58. Oyler, G.A., Polli, J.W., Higgins, G.A., Wilson, M.C., and Billingsley, M.L. 1992. Distribution and expression of SNAP-25 immunoreactivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma cells. Dev. Brain Res. 65: 133-146.
59. Pellegrini, L.L., O'Connor, V., Lottspeich, F., and Betz, H. 1995. Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion. EMBO J. 14: 4705-4713.
60. Pevsner, J., Hsu, S.C., Braun, J.E., Calakos, N., Ting, A.E., Bennett, M.K., and Scheller, R.H. 1994. Specificity and regulation of a synaptic vesicle docking complex. Neuron, 13: 353-361.
61. Raciborska, D.A., Trimble, W.S., and Charlton, M.P. 1998. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction. Eur. J. Neurosci. 10: 2617-2628.
62. Ravichandran, V., Chawla, A., and Roche, P.A. 1996. Identification of a novel syntaxin- and synaptobrevin/VAMP-binding protein, Snap-23, expressed in non-neuronal tissues. J. Biol. Chem. 271: 13 300 - 13 303.
63. Roth, D., and Burgoyne, R.D. 1994. SNAP-25 is present in a SNARE complex in adrenal chromaffin cells. FEBS Lett. 351: 207-210.
64. Sadoul, K., Berger, A., Niemann, H., Regazzi, R., Catsicas, S., and Halban, P.A. 1997. SNAP-25 can self-associate to form a disulfide-linked complex. Biol. Chem. 378: 1171-1176.
65. Sanders, J.D., Yang, Y., and Liu, Y. 1998. Differential turnover of syntaxin and SNAP-25 during synaptogenesis in cultured cerebellar granule neurons. J. Neurosci. Res. 53: 670-676.
66. Schantz, E.J., and Sugiyama, H. 1974. The toxins of Clostridium botulinum. Essays Toxicol. 5: 99-119.
67. Schiavo, G., Rossetto, O., Catsicas, S., Polverino de Laureto, P., DasGupta, B.R., Benfenati, F., and Montecucco, C. 1993a. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem. 268: 23 784 - 23 787.
68. Schiavo, G., Santucci, A., DasGupta, B.R., Mehta, P.P., Jontes, J., Benfenati, F., Wilson, M.C., and Montecucco, C. 1993b. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett. 335: 99-103.
69. Schiavo, G., Shone, C.C., Bennett, M.K., Scheller, R.H., and Montecucco, C. 1995. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270: 10 566 - 10 570.
70. 3H]γ-aminobutyric acid in rat hippocampal synaptosomes. Mol. Brain Res. 55: 337-340.
71. Shiff, G., and Morel, N. 1997. Association of syntaxin with SNAP-25 and VAMP (synaptobrevin) during axonal transport. J. Neurosci. Res. 48: 313-323.
72. Shone, C.C., and Melling, J. 1992. Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. Eur. J. Biochem. 207: 1009-1016.
73. Simpson, L.L. 1971. Ionic requirements for the neuromuscular blocking action of botulinum toxin: implications with regard to synaptic transmission. Neuropharmacology, 10: 673-684.
74. Simpson, L.L. 1981. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 33: 155-188.
75. Sloop, R.R., Cole, B.A., and Escutin, R.O. 1997. Human response to botulinum toxin injection: type B compared with type A. Neurology, 49: 189-194.
76. Söllner, T., Bennet, M.K., Whiteheart, S.W., Scheller, R.H., and Rothman, J.E. 1993a. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion. Cell, 75: 409-418.
77. Söllner, T., Whiteheart, S.W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J.E. 1993b. SNAP receptors implicated in vesicle targeting and fusion. Nature (London), 362: 318-324.
78. Sporns, O., and Jenkinson, S. 1997. Potassium ion- and nitric oxide-induced exocytosis from populations of hippocampal synapses during synaptic maturation in vitro. Neuroscience, 80: 1057-1073.
79. Stamler, J.S., Simon, D.I., Osborne, J.A., Mullins, M.E., Jaraki, O., Michel, T., Singel, D.J., and Loscalzo, J. 1992. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U.S.A. 89: 444-448.
80. Suzuki, T., Nakajima, K., Fujimoto, K., Fujii, T., and Kawashima, K. 1997. Nitric oxide increases stimulation-evoked acetylcholine release from rat hippocampal slices by a cyclic GMP-independent mechanism. Brain Res. 760: 158-162.
81. Vaidyanathan, V.V., Yoshino, K., Jahnz, M., Dörries, C., Bade, S., Nauenburg, S., Niemann, H., and Binz, T. 1999. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J. Neurochem. 72: 327-337.
82. Veit, M., Söllner, T.H., and Rothman, J.E. 1996. Multiple palmitoylation of synaptotagmin and the t-SNARE SNAP-25. FEBS Lett. 385: 119-123.
83. Walch-Solimena, C., Blasi, J., Lambert, E., Chapman, E.R., Fisher von Mollard, G., and Jahn, R. 1995. The t-SNAREs syntaxin 1 and SNAP-25 are present on organelles that participate in synaptic vesicle recycling. J. Cell Biol. 128: 637-645.
84. Washbourne, P., Pellizzari, R., Rossetto, O., Bortoletto, N., Tugnoli, V., De Grandis, D., Eleopra, R., and Montecucco, C. 1998. On the action of botulinum neurotoxins A and E at cholinergic terminals. J. Physiol. (Paris), 92: 135-139.
85. Yoshida, A., Oho, C., Omori, A., Kuwahara, R., Ito, T., and Takahashi, M. 1992. HPC-1 is associated with synaptotagmin and ω-conotoxin receptor. J. Biol. Chem. 267: 24 925 - 24 928.